Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. - Wikidata - wikimedia - TriplyDB

Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage.

Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage.

http://www.wikidata.org/entity/Q34189929

about

Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review Circulating miR-499 as a potential biomarker for acute myocardial infarction Exosomes Mediate the Intercellular Communication after Myocardial Infarction.Cardiac Extracellular Vesicles in Normal and Infarcted Heart Looking for Pyroptosis-Modulating miRNAs as a Therapeutic Target for Improving Myocardium Survival MicroRNAs; easy and potent targets in optimizing therapeutic methods in reparative angiogenesis Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease Epigenetic mechanisms underlying cardiac degeneration and regeneration Intercellular transport of microRNAs Small RNA Detection by in Situ Hybridization Methods Novel insights into miRNA in lung and heart inflammatory diseases Methodological challenges in utilizing miRNAs as circulating biomarkers miRNome in myocardial infarction: Future directions and perspective Systems Medicine as an Emerging Tool for Cardiovascular Genetics Mechanisms of RNA loading into exosomes Novel methodologies for biomarker discovery in atherosclerosis Circulating microRNA: a novel potential biomarker for early diagnosis of intracranial aneurysm rupture a case control study MicroRNA Regulatory Networks as Biomarkers in Obesity: The Emerging Role.Dynamic changes of serum microRNA-122-5p through therapeutic courses indicates amelioration of acute liver injury accompanied by acute cardiac decompensation Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly.The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes Exosomal miRNAs as potential biomarkers of cardiovascular risk in children.MicroRNAs expression profiles in cardiovascular diseases.Clinical impact of circulating miR-133, miR-1291 and miR-663b in plasma of patients with acute myocardial infarction.Plasma levels of microRNA-499 provide an early indication of perioperative myocardial infarction in coronary artery bypass graft patients.Circulating microRNAs, novel biomarkers of acute myocardial infarction: a systemic review HypoxamiR regulation and function in ischemic cardiovascular diseases.Atherosclerosis-related circulating miRNAs as novel and sensitive predictors for acute myocardial infarction Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth.The expression levels of plasma micoRNAs in atrial fibrillation patients.Aldosterone regulates microRNAs in the cortical collecting duct to alter sodium transport.The protective effect of microRNA-320 on left ventricular remodeling after myocardial ischemia-reperfusion injury in the rat model.Biomarkers of coronary artery disease: the promise of the transcriptome.Circulating miRNAs in cancer: from detection to therapy.Circulating miRNAs as potential marker for pulmonary hypertension.Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis.MiRNAs as biomarkers of myocardial infarction: a meta-analysis A critical evaluation of microRNA biomarkers in non-neoplastic disease Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology.

P2860

Q26746063-CE9F1413-8C3A-478F-92B8-E6B0A578C9B5 Q26750940-FCD280DA-E8C1-4FED-81DD-EEB27AECD914 Q26768620-EA22E768-31BC-4E9E-8516-59AD33EECB2A Q26770294-A96BA3F2-EA11-445C-B3AF-CC9C92CD56E4 Q26778539-76C96996-49AE-4F81-BC02-B4A64173E0CE Q26785405-EB0054F9-CA53-4427-8360-BB00AAE83DF1 Q26795757-F19701E4-9315-45C0-B2DC-D89C2EF495B3 Q26853220-F922805B-6A64-4467-9C21-FF8C3603B6CE Q27004360-6AEFF1DE-D730-4BE9-822C-7649EE9236B7 Q27011992-90A44EFF-5632-4813-9C8E-900D73590A00 Q27026348-661E605F-36F6-41A0-90BE-7C25AC9779F9 Q27027950-4B886D1C-F26A-41B5-A21A-2E413F59D4CF Q27028108-D32EE590-DA68-4FDB-880A-309ABDD525B4 Q28069197-B2EE5123-607B-4684-AFF5-148D4AFB811D Q28080927-8A2911CD-407A-42A6-8510-A5495E14CCFB Q28088373-3F91EB0B-500F-4CAB-AD44-1381159D6AF5 Q28652618-432F31DC-539A-46CB-923B-5255BE62AADA Q30402389-C1918BD2-C7DF-4D54-87FF-66D211878FED Q33577437-23F2FC87-92DD-4163-AD4D-C12B14DEE687 Q33616120-0CABDA4D-9B33-4A69-8DFE-2094851CF822 Q33624461-B2BA8561-883C-4D6E-B575-19458CC180D9 Q33671476-F6835CFE-E323-4627-9C57-6FC9D6A02AB2 Q33756578-22A604DF-AD89-4865-961A-E5DDC9CDA57D Q33821302-069F93BD-29FE-447F-88B5-522D43DA2F19 Q33847328-058DACB4-AD9D-4AAE-BA87-6780F3B0D575 Q34027681-5D9D6798-248F-41FD-AA81-E188DFAA02EC Q34032112-03162DCB-25EA-46D8-B09A-6946C1DD7D01 Q34082010-54764E3D-5162-40C9-992C-5D0F15A5881E Q34128444-1D269383-643F-488B-8163-7C1FCE8EE800 Q34275817-03045264-6A0A-4B88-9849-AF7BB876558B Q34427635-5903F551-33F6-4629-9A3D-AC0C143DF7CB Q34427641-0F5713C6-07E0-4194-B5AE-328B69BF0E9F Q34486554-F2DC919F-728F-4873-B399-F958A3874FC4 Q34507146-634D9D2F-AEA2-421F-9D75-9EA05D8EE772 Q34728385-E7FBAC39-8033-462F-8DF4-3FB58DEE3D1E Q34745818-C34914F4-D180-4C27-9C5C-65CE78A074E2 Q34853050-4A79FA39-185B-4AF9-BCD9-9F3DD7618165 Q35095427-2770B040-7EB5-45C2-B3C2-C532328B28F9 Q35107632-667598A0-EE34-4534-8D29-1E23EE262F61 Q35112471-48607978-245E-489A-A093-62C3C8E9848F

P2860

Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage.

http://www.wikidata.org/entity/Q34189929

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Increased microRNA-1 and micro ...... se indicate myocardial damage.

@ast

Increased microRNA-1 and micro ...... se indicate myocardial damage.

@en

Increased microRNA-1 and micro ...... se indicate myocardial damage.

@nl

type

label

Increased microRNA-1 and micro ...... se indicate myocardial damage.

@ast

Increased microRNA-1 and micro ...... se indicate myocardial damage.

@en

Increased microRNA-1 and micro ...... se indicate myocardial damage.

@nl

prefLabel

Increased microRNA-1 and micro ...... se indicate myocardial damage.

@ast

Increased microRNA-1 and micro ...... se indicate myocardial damage.

@en

Increased microRNA-1 and micro ...... se indicate myocardial damage.

@nl

P1433

Q34189929-3D366767-FAC0-43D9-B357-FF9DA3DA7F13

P1476

Q34189929-0247CA82-F6C7-4803-B4E4-6A11D7282D8F

P2093

Q34189929-0073EA58-7EDC-4B74-8069-D74C1985416A

Q34189929-0DB850A7-5837-468F-BD86-7C604466DA34

Q34189929-0ED0EF76-1EE3-4040-9A6B-2438B27BDFB3

Q34189929-34CB63E3-0716-43A6-B68C-541A6BD6E07C

Q34189929-38FFF8AC-E319-4584-97A4-BEC08E6AC1AC

Q34189929-50D8E547-A6D2-4004-AD22-18E7EABCA15C

Q34189929-58FC5727-517D-46FA-9DD6-A9EB8B2C6A9F

Q34189929-651B3112-B3D8-4A97-9A18-AF0385D5F4B5

Q34189929-89522820-6C02-4A95-B333-90269CC358A5

Q34189929-A1ACFE41-116F-4AA3-B913-684B8D642D4E

P304

Q34189929-A3254C20-A371-46BA-A4A5-73E8B5CE3D37

P31

Q34189929-25807250-41AD-42E3-B64A-0BE2BC1745FC

P356

Q34189929-849720B6-343A-43C4-88AC-0FF176FBC41F

P433

Q34189929-50EBC6DA-E366-4AF0-944E-4A9EE5D8A0FF

P478

Q34189929-64E51228-0135-4827-BEC6-A77D6B69F84A

P577

Q34189929-FDCA34E1-C4D1-4504-BBEC-7E819530D4ED

P5875

Q34189929-6AB540B5-C2D2-4936-BA5E-A20F8F3DECCB

P698

Q34189929-B36A12CB-2452-4ADD-AE80-CE95B341A1AB

P921

Q34189929-2F62C2E3-E55A-4612-9777-3C78EF48D291

Q34189929-A8D32AFB-4F41-4E16-AE7A-C1B0B80098CD

Q34189929-B46F18C0-A8F4-4AD6-ACD3-AD1F8CB7C35E

P356

CIRCGENETICS.110.958975

P1433

Circulation: Cardiovascular Genetics

P1476

Increased microRNA-1 and micro ...... se indicate myocardial damage.

@en

P2093

Hitoo Nishi

http://www.w3.org/2001/XMLSchema#string

Kazuya Nagao

http://www.w3.org/2001/XMLSchema#string

Koh Ono

http://www.w3.org/2001/XMLSchema#string

Masao Imai

http://www.w3.org/2001/XMLSchema#string

Minako Kinoshita

http://www.w3.org/2001/XMLSchema#string

Osamu Baba

http://www.w3.org/2001/XMLSchema#string

Satoshi Shizuta

http://www.w3.org/2001/XMLSchema#string

Shin Watanabe

http://www.w3.org/2001/XMLSchema#string

Takahiro Horie

http://www.w3.org/2001/XMLSchema#string

Takeshi Kimura

http://www.w3.org/2001/XMLSchema#string

P304

446-454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCGENETICS.110.958975

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51192525

http://www.w3.org/2001/XMLSchema#string

P698

21642241

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease